Impact of nanotechnology in cancer: emphasis on nanochemoprevention

References

• NieSXingYKimGJSimonsJWNanotechnology applications in cancerAnnu Rev Biomed Eng2007925728817439359
   PubMed Web of Science ®Google Scholar
• NiemeyerCMSemi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnologyJ Biotechnol2001821476611999713
   PubMedGoogle Scholar
• NishiyamaNNanomedicine: nanocarriers shape up for long lifeNat Nanotechnol20072420320418654260
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
   PubMed Web of Science ®Google Scholar
• CuencaAGJiangHHochwaldSNDelanoMCanceWGGrobmyerSREmerging implications of nanotechnology on cancer diagnostics and therapeuticsCancer2006107345946616795065
   PubMed Web of Science ®Google Scholar
• WangXYangLChenZGShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin20085829711018227410
   PubMed Web of Science ®Google Scholar
• McNeilSENanoparticle therapeutics: a personal perspectiveWiley Interdiscip Rev Nanomed Nanobiotechnol20091326427120049796
   PubMed Web of Science ®Google Scholar
• FreitasRAJrWhat is nanomedicine?Nanomedicine2005112917292052
   PubMed Web of Science ®Google Scholar
• FreitasRAJrCurrent status of nanomedicine and medical nanoroboticsJ Comput Theor Nanos200521125
   Google Scholar
• TorchilinVAntibody-modified liposomes for cancer chemotherapyExpert Opin Drug Deliv2008591003102518754750
   PubMed Web of Science ®Google Scholar
• VasirJKLabhasetwarVBiodegradable nanoparticles for cytosolic delivery of therapeuticsAdv Drug Deliv Rev200759871872817683826
   PubMed Web of Science ®Google Scholar
• SahooSKLabhasetwarVNanotech approaches to drug delivery and imagingDrug Discov Today20038241112112014678737
   PubMed Web of Science ®Google Scholar
• BarretoJAO’MalleyWKubeilMGrahamBStephanHSpicciaLNanomaterials: applications in cancer imaging and therapyAdv Mater20112312H184021433100
   PubMed Web of Science ®Google Scholar
• JudsonIRadfordJAHarrisMRandomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupEur J Cancer200137787087711313175
   PubMed Web of Science ®Google Scholar
• HubertALyassOPodeDGabizonADoxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancerAnticancer Drugs200011212312710789595
   PubMed Web of Science ®Google Scholar
• ForssenEAMale-BruneRAdler-MooreJPFluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissueCancer Res1996569206620758616852
   PubMed Web of Science ®Google Scholar
• GuaglianonePChanKDelaFlor-WeissEPhase I and pharmacologic study of liposomal daunorubicin (DaunoXome)Invest New Drugs19941221031107860226
   PubMed Web of Science ®Google Scholar
• JaeckleKABatchelorTO’DaySJAn open label trial of sustained- release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisJ Neurooncol200257323123912125986
   PubMed Web of Science ®Google Scholar
• GlantzMJJaeckleKAChamberlainMCA randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Res19995113394340210589750
   PubMed Web of Science ®Google Scholar
• Vincristine liposomal – INEX: lipid-encapsulated vincristine, Onco TCS, transmembrane carrier system – vincristine, vincacine, vincristine sulfate liposomes for injection, VSLIDrugs R D20045211912315293876
   PubMedGoogle Scholar
• FassasAAnagnostopoulosAThe use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemiaLeuk Lymphoma200546679580216019523
   PubMed Web of Science ®Google Scholar
• CharroisGJAllenTMDrug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancerBiochim Biophys Acta200416631–216717715157619
   PubMed Web of Science ®Google Scholar
• SimoesSMoreiraJNFonsecaCDuzgunesNde LimaMCOn the formulation of pH-sensitive liposomes with long circulation timesAdv Drug Deliv Rev200456794796515066754
   PubMed Web of Science ®Google Scholar
• LeamonCPCooperSRHardeeGEFolate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivoBioconjug Chem200314473874712862426
   PubMed Web of Science ®Google Scholar
• OriveGGasconARHernandezRMDominguez-GilAPedrazJLTechniques: new approaches to the delivery of biopharmaceuticalsTrends Pharmacol Sci200425738238715219981
   PubMed Web of Science ®Google Scholar
• SlingerlandMGuchelaarHJGelderblomHLiposomal drug formulations in cancer therapy: 15 years along the roadDrug Discov Today9292011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• ChanAShihVTham CheeKLiposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measuresJ Oncol Pharm Pract200713210510717873110
   PubMedGoogle Scholar
• SzebeniJComplement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteinsCurr Drug Deliv20052444344916305447
   PubMedGoogle Scholar
• VealGJGriffinMJPriceEA phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatinBr J Cancer20018481029103511308249
   PubMed Web of Science ®Google Scholar
• WhiteSCLoriganPMargisonGPPhase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBr J Cancer200695782282816969346
   PubMed Web of Science ®Google Scholar
• SteeleJPO’DohertyCAShamashJPhase II trial of liposomal daunorubicin in malignant pleural mesotheliomaAnn Oncol200112449749911398882
   PubMed Web of Science ®Google Scholar
• XingYSmithAMAgrawalARuanGNieSMolecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dotsInt J Nanomedicine20061447348117722280
   PubMed Web of Science ®Google Scholar
• SeydelCQuantum dots get wetScience20033005616808112677056
   PubMed Web of Science ®Google Scholar
• BruchezMJrMoronneMGinPWeissSAlivisatosAPSemiconductor nanocrystals as fluorescent biological labelsScience19982815385201320169748157
   PubMed Web of Science ®Google Scholar
• PinaudFMichaletXBentolilaLAAdvances in fluorescence imaging with quantum dot bio-probesBiomaterials20062791679168716318871
   PubMed Web of Science ®Google Scholar
• GaoXYangLPetrosJAMarshallFFSimonsJWNieSIn vivo molecular and cellular imaging with quantum dotsCurr Opin Biotechnol2005161637215722017
   PubMed Web of Science ®Google Scholar
• MichaletXPinaudFFBentolilaLAQuantum dots for live cells, in vivo imaging, and diagnosticsScience2005307570953854415681376
   PubMed Web of Science ®Google Scholar
• AlivisatosPThe use of nanocrystals in biological detectionNat Biotechnol2004221475214704706
   PubMed Web of Science ®Google Scholar
• ShioharaAHoshinoAHanakiKSuzukiKYamamotoKOn the cyto-toxicity caused by quantum dotsMicrobiol Immunol200448966967515383704
   PubMed Web of Science ®Google Scholar
• LovricJBazziHSCuieYFortinGRWinnikFMMaysingerDDifferences in subcellular distribution and toxicity of green and red emitting CdTe quantum dotsJ Mol Med (Berl)200583537738515688234
   PubMed Web of Science ®Google Scholar
• HoshinoAManabeNFujiokaKSuzukiKYasuharaMYamamotoKUse of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicityJ Artif Organs200710314915717846713
   PubMed Web of Science ®Google Scholar
• ChoiAOChoSJDesbaratsJLovricJMaysingerDQuantum dot- induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cellsJ Nanobiotechnol200751
   PubMedGoogle Scholar
• GaoXChungLWNieSQuantum dots for in vivo molecular and cellular imagingMethods Mol Biol200737413514517237536
   PubMedGoogle Scholar
• SmithAMRuanGRhynerMNNieSEngineering luminescent quantum dots for in vivo molecular and cellular imagingAnn Biomed Eng200634131416450199
   PubMed Web of Science ®Google Scholar
• DubertretBSkouridesPNorrisDJNoireauxVBrivanlouAHLibchaberAIn vivo imaging of quantum dots encapsulated in phospholipid micellesScience200229855991759176212459582
   PubMed Web of Science ®Google Scholar
• RawatMSinghDSarafSNanocarriers: promising vehicle for bioactive drugsBiol Pharm Bull20062991790179816946487
   PubMed Web of Science ®Google Scholar
• HamaguchiTMatsumuraYSuzukiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer20059271240124615785749
   PubMed Web of Science ®Google Scholar
• LavasanifarASamuelJKwonGSPoly(ethylene oxide)-block-poly(L-amino acid) micelles for drug deliveryAdv Drug Deliv Rev200254216919011897144
   PubMed Web of Science ®Google Scholar
• BaeYNishiyamaNFukushimaSKoyamaHYasuhiroMKataokaKPreparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacyBioconjug Chem200516112213015656583
   PubMed Web of Science ®Google Scholar
• NakanishiTFukushimaSOkamotoKDevelopment of the polymer micelle carrier system for doxorubicinJ Control Release2001741–329530211489509
   PubMed Web of Science ®Google Scholar
• TorchilinVPLukyanovANGaoZPapahadjopoulos-SternbergBImmunomicelles: targeted pharmaceutical carriers for poorly soluble drugsProc Natl Acad Sci U S A2003100106039604412716967
   PubMed Web of Science ®Google Scholar
• MohantyCAcharyaSMohantyAKDilnawazFSahooSKCurcumin- encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapyNanomedicine (Lond)20105343344920394536
   PubMed Web of Science ®Google Scholar
• WuGDatarRHHansenKMThundatTCoteRJMajumdarABioassay of prostate-specific antigen (PSA) using microcantileversNat Biotechnol200119985686011533645
   PubMed Web of Science ®Google Scholar
• TekadeRKKumarPVJainNKDendrimers in oncology: an expanding horizonChem Rev20091091498719099452
   PubMed Web of Science ®Google Scholar
• SvensonSTomaliaDADendrimers in biomedical applications – reflections on the fieldAdv Drug Deliv Rev200557152106212916305813
   PubMed Web of Science ®Google Scholar
• TomaliaDASupramolecular chemistry: fluorine makes a differenceNat Mater200321171171214593393
   PubMed Web of Science ®Google Scholar
• ChoiYThomasTKotlyarAIslamMTBakerJRJrSynthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targetingChem Biol2005121354315664513
   PubMedGoogle Scholar
• XuHReginoCAKoyamaYPreparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imagingBioconjug Chem20071851474148217711320
   PubMed Web of Science ®Google Scholar
• KobayashiHBrechbielMWDendrimer-based macromolecular MRI contrast agents: characteristics and applicationMol Imaging20032111012926232
   PubMedGoogle Scholar
• JiangYHEmauPCairnsJSSPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaquesAIDS Res Hum Retroviruses200521320721315795526
   PubMed Web of Science ®Google Scholar
• GrodzinskiPSilverMMolnarLKNanotechnology for cancer diagnostics: promises and challengesExpert Rev Mol Diagn20066330731816706735
   PubMed Web of Science ®Google Scholar
• NuneSKGundaPThallapallyPKLinYYForrestMLBerklandCJNanoparticles for biomedical imagingExpert Opin Drug Deliv20096111175119419743894
   PubMed Web of Science ®Google Scholar
• BiancoAKostarelosKPartidosCDPratoMBiomedical applications of functionalised carbon nanotubesChem Commun (Camb)2005557157715672140
   PubMed Web of Science ®Google Scholar
• BachiloSMStranoMSKittrellCHaugeRHSmalleyREWeismanRBStructure-assigned optical spectra of single-walled carbon nanotubesScience200229856022361236612459549
   PubMed Web of Science ®Google Scholar
• PastorinGWuWWieckowskiSDouble functionalization of carbon nanotubes for multimodal drug deliveryChem Commun (Camb)2006111182118416518484
   PubMed Web of Science ®Google Scholar
• RadomskiAJuraszPAlonso-EscolanoDNanoparticle-induced platelet aggregation and vascular thrombosisBr J Pharmacol2005146688289316158070
   PubMed Web of Science ®Google Scholar
• WarheitDBLaurenceBRReedKLRoachDHReynoldsGAWebbTRComparative pulmonary toxicity assessment of single-wall carbon nanotubes in ratsToxicol Sci200477111712514514968
   PubMed Web of Science ®Google Scholar
• MullerJHuauxFMoreauNRespiratory toxicity of multi-wall carbon nanotubesToxicol Appl Pharmacol2005207322123116129115
   PubMed Web of Science ®Google Scholar
• De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
   PubMed Web of Science ®Google Scholar
• YinJJLaoFMengJInhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavengerMol Pharmacol20087441132114018635669
   PubMed Web of Science ®Google Scholar
• MisraRAcharyaSSahooSKCancer nanotechnology: application of nanotechnology in cancer therapyDrug Discov Today20101519–2084285020727417
   PubMed Web of Science ®Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
   PubMed Web of Science ®Google Scholar
• PortneyNGOzkanMNano-oncology: drug delivery, imaging, and sensingAnal Bioanal Chem2006384362063016440195
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• KawasakiESPlayerANanotechnology, nanomedicine, and the development of new, effective therapies for cancerNanomedicine20051210110917292064
   PubMed Web of Science ®Google Scholar
• GrefRDombAQuellecPThe controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresAdv Drug Deliv Rev1995162–3215233
   PubMed Web of Science ®Google Scholar
• DengCTianHZhangPSunJChenXJingXSynthesis and characterization of RGD peptide grafted poly(ethylene glycol)- b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymerBiomacromolecules20067259059616471935
   PubMed Web of Science ®Google Scholar
• MosqueiraVCLegrandPMorgatJLBiodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and densityPharm Res200118101411141911697466
   PubMed Web of Science ®Google Scholar
• StolnikSDunnSEGarnettMCSurface modification of poly(lactide-co- glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymersPharm Res19941112180018087899246
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemo-prevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res20096951712171619223530
   PubMed Web of Science ®Google Scholar
• ShutavaTGBalkundiSSVangalaPLayer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenolsACS Nano2009371877188519534472
   PubMed Web of Science ®Google Scholar
• ShutavaTGBalkundiSSLvovYM(−)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsulesJ Colloid Interface Sci2009330227628319027120
   PubMed Web of Science ®Google Scholar
• BarrasAMezzettiARichardAFormulation and characterization of polyphenol-loaded lipid nanocapsulesInt J Pharm2009379227027719501139
   PubMed Web of Science ®Google Scholar
• ZuYGYuanSZhaoXHZhangYZhangXNJiangRPreparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticlesYao Xue Xue Bao2009445525531 Chinese19618731
   PubMedGoogle Scholar
• DubeANicolazzoJALarsonIChitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallateEur J Pharm Sci201041221922520600878
   PubMed Web of Science ®Google Scholar
• HanDWLeeJJJungDYParkJCHyonSHDevelopment of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluationsBiomed Mater20094444104
   Web of Science ®Google Scholar
• ItaliaJLDattaPAnkolaDDKumarMNVRNanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solutionJ Biomed Nanotechnol20084304312
   Web of Science ®Google Scholar
• RochaSGeneralovRdo PereiraMCPeresIJuzenasPCoelhoMAEpigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemopreventionNanomedicine (Lond)201161798721182420
   PubMed Web of Science ®Google Scholar
• SinghMBhatnagarPSrivastavaAKKumarPShuklaYGuptaKCEnhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticlesJ Biomed Nanotechnol20117120221485870
   PubMed Web of Science ®Google Scholar
• HsiehDSWangHTanSWThe treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticlesBiomaterials201132307633764021782236
   PubMed Web of Science ®Google Scholar
• AzizMHReagan-ShawSWuJLongleyBJAhmadNChemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?FASEB J20051991193119515837718
   PubMed Web of Science ®Google Scholar
• AzizMHKumarRAhmadNCancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review)Int J Oncol2003231172812792772
   PubMed Web of Science ®Google Scholar
• BhatKPPezzutoJMCancer chemopreventive activity of resveratrolAnn N Y Acad Sci200295721022912074974
   PubMed Web of Science ®Google Scholar
• YaoQHouSXHeWLStudy on the preparation of resveratrol chitosan nanoparticles with free amino groups on the surfaceZhongguo Zhong Yao Za Zhi2006313205208 Chinese16572999
   PubMedGoogle Scholar
• ShaoJLiXLuXEnhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levelsColloids Surf B Biointerfaces2009721404719395246
   PubMed Web of Science ®Google Scholar
• LuXJiCXuHResveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stressInt J Pharm20093751–2899619481694
   PubMed Web of Science ®Google Scholar
• NarayananNKNargiDRandolphCNarayananBALiposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout miceInt J Cancer200912511819326431
   PubMed Web of Science ®Google Scholar
• KobierskiSOfori-KwakyeKMullerRHKeckCMResveratrol nanosuspensions for dermal application – production, characterization, and physical stabilityPharmazie2009641174174720099519
   PubMed Web of Science ®Google Scholar
• TeskacKKristlJThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrolInt J Pharm20103901616919833178
   PubMed Web of Science ®Google Scholar
• YadavVRAggarwalBBCurcumin: A component of the golden spice, targets multiple angiogenic pathwaysCancer Biol Ther201111223624121191188
   PubMed Web of Science ®Google Scholar
• TonnesenHHSolubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIIIPharmazie2002571282082412561244
   PubMed Web of Science ®Google Scholar
• TiyaboonchaiWTungpraditWPlianbangchangPFormulation and characterization of curcuminoids loaded solid lipid nanoparticlesInt J Pharm20073371–229930617287099
   PubMed Web of Science ®Google Scholar
• BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
   PubMedGoogle Scholar
• SahuABoraUKasojuNGoswamiPSynthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cellsActa Biomater2008461752176118524701
   PubMed Web of Science ®Google Scholar
• ThangapazhamRLPuriATeleSBlumenthalRMaheshwariRKEvaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cellsInt J Oncol20083251119112318425340
   PubMed Web of Science ®Google Scholar
• DasRKKasojuNBoraUEncapsulation of curcumin in alginate-chitosan- pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
   PubMed Web of Science ®Google Scholar
• MerrellJGMcLaughlinSWTieLLaurencinCTChenAFNairLSCurcumin loaded poly(epsilon-caprolactone) nanofibers: diabetic wound dressing with antioxidant and anti-inflammatory propertiesClin Exp Pharmacol Physiol200936121149115619473187
   PubMed Web of Science ®Google Scholar
• LiJWangYYangCPolyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1Mol Pharmacol2009761819019395473
   PubMed Web of Science ®Google Scholar
• ShaikhJAnkolaDDBeniwalVSinghDKumarMNNanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEur J Pharm Sci2009373–422323019491009
   PubMed Web of Science ®Google Scholar
• DasRKKasojuNBoraUEncapsulation of curcumin in alginatechitosan- pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
   PubMed Web of Science ®Google Scholar
• AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Pharmacol201079333033819735646
   PubMed Web of Science ®Google Scholar
• MukerjeeAVishwanathaJKFormulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapyAnticancer Res200929103867387519846921
   PubMed Web of Science ®Google Scholar
• OnoueSTakahashiHKawabataYFormulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailabilityJ Pharm Sci20109941871188119827133
   PubMed Web of Science ®Google Scholar
• SouKOyajobiBGoinsBPhillipsWTTsuchidaECharacterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol)J Biomed Nanotechnol20095220220820055098
   PubMed Web of Science ®Google Scholar
• PrajaktaDRatneshJChandanKCurcumin loaded pH-sensitive nanoparticles for the treatment of colon cancerJ Biomed Nanotechnol20095544545520201417
   PubMed Web of Science ®Google Scholar
• YallapuMMGuptaBKJaggiMChauhanSCFabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cellsJ Colloid Interface Sci20103511192920627257
   PubMed Web of Science ®Google Scholar
• YallapuMMMaherDMSundramVBellMCJaggiMChauhanSCCurcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJ Ovarian Res201031120429876
   PubMed Web of Science ®Google Scholar
• RozziANardoniCCoronaMRestucciaMRFalboTLanzettaGWeekly regimen of paclitaxel and carboplatin as first-line chemotherapy in elderly patients with stage IIIB-IV non small cell lung cancer (NSCLC): results of a Phase II studyJ Chemother201122641942321303751
   PubMed Web of Science ®Google Scholar
• GuptaSCKimJHPrasadSAggarwalBBRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer Metastasis Rev201029340543420737283
   PubMed Web of Science ®Google Scholar
• WuYYChangJYChaoTYPaclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: a report of two cases and review of the literatureTumori201096233633920572596
   PubMed Web of Science ®Google Scholar
• GeorgeJBanikNLRaySKCombination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growthJ Cell Mol Med200913104205421819473291
   PubMed Web of Science ®Google Scholar
• FonsecaCSimoesSGasparRPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release200283227328612363453
   PubMed Web of Science ®Google Scholar
• FengSSMuLWinKYHuangGNanoparticles of biodegradable polymers for clinical administration of paclitaxelCurr Med Chem200411441342414965222
   PubMed Web of Science ®Google Scholar
• OnyukselHJeonERubinsteinINanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cellsCancer Lett2009274232733019022562
   PubMed Web of Science ®Google Scholar
• SahooSKMaWLabhasetwarVEfficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancerInt J Cancer2004112233534015352049
   PubMed Web of Science ®Google Scholar
• VanSDasSKWangXSynthesis, characterization, and biological evaluation of poly(L-gamma-glutamyl-glutamine)- paclitaxel nanoconjugateInt J Nanomedicine2010582583721042550
   PubMed Web of Science ®Google Scholar
• LeeALWangYPervaizSFanWYangYYSynergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micellesMacromol Biosci2011112296230721154473
   PubMed Web of Science ®Google Scholar
• BharaliDJKhalilMGurbuzMSimoneTMMousaSANanoparticles and cancer therapy: a concise review with emphasis on dendrimersInt J Nanomedicine2009411719421366
   PubMed Web of Science ®Google Scholar
• BharaliDJLuceyDWJayakumarHPudavarHEPrasadPNFolate- receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopyJ Am Chem Soc200512732113641137116089466
   PubMed Web of Science ®Google Scholar
• ChatterjeeDKFongLSZhangYNanoparticles in photodynamic therapy: an emerging paradigmAdv Drug Deliv Rev200860151627163718930086
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano200931162019206243
   PubMed Web of Science ®Google Scholar
• ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
   PubMed Web of Science ®Google Scholar
• BlagosklonnyMVHow cancer could be cured by 2015Cell Cycle20054226927815655345
   PubMed Web of Science ®Google Scholar